Flagship Ventures Fund V, L.p. - Net Worth and Insider Trading
Flagship Ventures Fund V, L.p. Net Worth
The estimated net worth of Flagship Ventures Fund V, L.p. is at least $85 Million dollars as of 2024-11-29. Flagship Ventures Fund V, L.p. is the 10% Owner of Sana Biotechnology Inc and owns about 33,290,018 shares of Sana Biotechnology Inc (SANA) stock worth over $85 Million. Flagship Ventures Fund V, L.p. is the 10% Owner of Codiak BioSciences Inc and owns about 2,607,303 shares of Codiak BioSciences Inc (CDAKQ) stock worth over $4,172. Flagship Ventures Fund V, L.p. is also the 10% Owner of Kaleido Biosciences Inc and owns about 14,504,284 shares of Kaleido Biosciences Inc (KLDO) stock worth over $1,450. Details can be seen in Flagship Ventures Fund V, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Flagship Ventures Fund V, L.p. has not made any transactions after 2023-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Flagship Ventures Fund V, L.p.
Flagship Ventures Fund V, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Fund V, L.p. owns 9 companies in total, including Foghorn Therapeutics Inc (FHTX) , Codiak BioSciences Inc (CDAKQ) , and Kaleido Biosciences Inc (KLDO) among others .
Click here to see the complete history of Flagship Ventures Fund V, L.p.’s form 4 insider trades.
Insider Ownership Summary of Flagship Ventures Fund V, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-22 | 10 percent owner |
| CDAKQ | Codiak BioSciences Inc | 2020-10-16 | 10 percent owner |
| KLDO | Kaleido Biosciences Inc | 2019-03-04 | 10 percent owner |
 | | 2021-03-19 | 10 percent owner |
| | 2018-05-08 | 10 percent owner |
| | 2017-12-07 | 10 percent owner |
| | 2023-06-07 | 10 percent owner |
| | 2020-12-03 | 10 percent owner |
| | 2021-07-29 | 10 percent owner |
Flagship Ventures Fund V, L.p. Latest Holdings Summary
Flagship Ventures Fund V, L.p. currently owns a total of 3 stocks. Among these stocks, Flagship Ventures Fund V, L.p. owns 33,290,018 shares of Sana Biotechnology Inc (SANA) as of June 7, 2023, with a value of $85 Million and a weighting of 99.99%. Flagship Ventures Fund V, L.p. owns 2,607,303 shares of Codiak BioSciences Inc (CDAKQ) as of October 16, 2020, with a value of $4,172 and a weighting of 0%. Flagship Ventures Fund V, L.p. also owns 14,504,284 shares of Kaleido Biosciences Inc (KLDO) as of March 4, 2019, with a value of $1,450 and a weighting of 0%.
Latest Holdings of Flagship Ventures Fund V, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SANA | Sana Biotechnology Inc | 2023-06-07 | 33,290,018 | 2.55 | 84,889,546 |
| CDAKQ | Codiak BioSciences Inc | 2020-10-16 | 2,607,303 | 0.00 | 4,172 |
| KLDO | Kaleido Biosciences Inc | 2019-03-04 | 14,504,284 | 0.00 | 1,450 |
Holding Weightings of Flagship Ventures Fund V, L.p.
Flagship Ventures Fund V, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Flagship Ventures Fund V, L.p. has made a total of 2 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sana Biotechnology Inc is the sale of 403,758 shares on June 7, 2023, which brought Flagship Ventures Fund V, L.p. around $3 Million.
According to the SEC Form 4 filings, Flagship Ventures Fund V, L.p. has made a total of 1 transactions in Codiak BioSciences Inc (CDAKQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Codiak BioSciences Inc is the acquisition of 165,000 shares on October 16, 2020, which cost Flagship Ventures Fund V, L.p. around $2 Million.
According to the SEC Form 4 filings, Flagship Ventures Fund V, L.p. has made a total of 0 transactions in Kaleido Biosciences Inc (KLDO) over the past 5 years. The most-recent trade in Kaleido Biosciences Inc is the acquisition of 933,333 shares on March 4, 2019, which cost Flagship Ventures Fund V, L.p. around $14 Million.
Insider Trading History of Flagship Ventures Fund V, L.p.
- 1
Flagship Ventures Fund V, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Flagship Ventures Fund V, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Flagship Ventures Fund V, L.p. is 70.78%. GuruFocus also compares Flagship Ventures Fund V, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Flagship Ventures Fund V, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Flagship Ventures Fund V, L.p.'s insider trading performs compared to the benchmark.
Performance of Flagship Ventures Fund V, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.27 | | | | | |
| Relative Return to S&P 500(%) | -21.87 | | | | | |
Flagship Ventures Fund V, L.p. Ownership Network
Flagship Ventures Fund V, L.p. Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Flagship Ventures Fund V, L.p. is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Flagship Ventures Fund V, L.p. made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 58,859 shares made by Carlos Costa , a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 20,000 shares made by Steven F. Bellon .
In summary, during the past 3 months, insiders sold 78,859 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 78,859 shares. During the past 18 months, 401,156 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 401,156 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Flagship Ventures Fund V, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Ventures Fund V, L.p.. You might contact Flagship Ventures Fund V, L.p. via mailing address: One Memorial Drive, 7th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
